NCT03742037 Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus Status COMPLETED Phase PHASE2
NCT03724916 A Study to Evaluate the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-079 in Combination With Standard Background Therapy in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE) Status COMPLETED Phase PHASE1
NCT03684564 RIvaroxaban for Stroke Patients With AntiPhospholipid Syndrome Status COMPLETED Phase PHASE2
NCT03656627 Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease Status TERMINATED Phase PHASE1
NCT03618056 Evaluating HIV-1 Neutralization Antibody Breadth in Response to HIV gp120 Protein Vaccine in HIV-uninfected Adults With Quiescent Systemic Lupus Erythematosus Status COMPLETED Phase PHASE1
NCT03616964 A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE-BRAVE II) Status COMPLETED Phase PHASE3
NCT03616912 A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus Status TERMINATED Phase PHASE3
NCT03575156 Microparticles's Role in the Pathophysiology of Systemic Lupus Erythematosus and Systemic Sclerosis Status COMPLETED Phase NA
NCT03556007 A Study of NKTR-358 (LY3471851) in Participants With Systemic Lupus Erythematosus (SLE) Status COMPLETED Phase PHASE1
NCT03541564 An Investigational Study of Experimental Medication BMS-986165 in Healthy Participants to Study Electrocardiogram Effects Status COMPLETED Phase PHASE1
NCT03537638 Multicomponent Strategy to Implement a Clinical Practice Guideline and Improve Health Outcomes in People With SLE Status COMPLETED Phase NA
NCT03459274 Feasibility of an Immersive Virtual Reality Based Biofeedback Intervention for Outpatients in Rheumatology Status UNKNOWN Phase N/A
NCT03451422 Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Efavaleukin Alfa in Participants With Systemic Lupus Erythematosus Status COMPLETED Phase PHASE1
NCT03446339 Pulmonary Hypertension Screening for Rheumatology Patients (SOPHIE) Status UNKNOWN Phase N/A
NCT03396393 Exploratory Study of DHA in Systemic Lupus Erythematosus Patients Status UNKNOWN Phase PHASE2